Palantir tool has not cut hospital discharge delays, study says - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
商业快报

Palantir tool has not cut hospital discharge delays, study says

Think-tank’s findings likely to add to calls for audit of NHS England claims around Federated Data Platform
00:00

{"text":[[{"start":7.85,"text":"Hospitals using Palantir’s patient discharge tool have registered “no noticeable improvement” in performance, according to research that is likely to add to calls for an independent audit of NHS England’s claims."}],[{"start":20.15,"text":"There was also “no meaningful difference” in discharge delays at NHS trusts that had adopted the tool and those that had not, according to analysis by the Health Foundation, which was shared with the FT."}],[{"start":32.2,"text":"The think-tank’s findings are at odds with NHS England’s (NHSE) widely cited claim of a 15 per cent fall in long-stay discharge delays at hospitals using the Federated Data Platform, which Palantir won a £330mn contract to build in 2023."}],[{"start":49.800000000000004,"text":"The system for linking disparate datasets is being rolled out across the health service, with the aim of boosting efficiency. But it has come under scrutiny because of concerns about the US technology company’s ties to the defence sector and a lack of evidence for the platform’s effectiveness. "}],[{"start":66.9,"text":"NHSE analysed delay days for long-stay patients, those in hospital for at least a week, while the Health Foundation looked at the share of beds occupied by any patients with a delayed discharge."}],[{"start":78.30000000000001,"text":"“We found no noticeable improvement in discharge performance among trusts using [Palantir’s patient-tracking tool],” the Health Foundation said in a letter to the Office for Statistics Regulation, the watchdog. "}],[{"start":90.45000000000002,"text":"The “gradual upward trend in performance” observed at trusts before they had deployed the tool “continued at broadly the same rate” afterwards, it added."}],[{"start":null,"text":"

"}],[{"start":100.00000000000001,"text":"Jonathan Clarke, senior policy fellow at the Health Foundation, said the analysis used the “broadest view” of whether performance had improved, adding that focusing on patients with longer stays “may not capture the full picture”."}],[{"start":112.85000000000001,"text":"An internal NHSE document, seen by the FT, said health service officials had restricted their analysis to long-stay discharges because the tool was “mainly designed to support the management of complex patients”. "}],[{"start":126.25000000000001,"text":"Applying the think-tank’s method to long-stay patient data suggested a decline of about 5 per cent, one-third of the headline claim. However, “we agree . . . there does not seem to be an impact” when the method is applied to all patients with a delayed discharge, the NHSE document noted."}],[{"start":143.60000000000002,"text":"Steve Black, a healthcare consultant and former NHS data scientist, said the Health Foundation’s report added to the case for an independent audit of the data around the impact of the FDP. "}],[{"start":155.50000000000003,"text":"“It is dangerous to selectively quote evidence like that because its success should be judged against fixing the underlying problem, which is how do we better manage all discharges to free up more beds,” Black said. “The health service does not want to do evaluation properly. They come up with ideas and then look for evidence.” "}],[{"start":null,"text":"
"}],[{"start":174.70000000000002,"text":"The internal NHSE document acknowledged the need to “move beyond observational data” and “assess impact in a more rigorous way” by using methods that controlled for other factors. "}],[{"start":186.65,"text":"NHSE awarded a contract for a “robust, independent evaluation” of the FDP to Imperial College London this year, but the university’s final report is not expected until 2029."}],[{"start":199.85,"text":"The Health Foundation’s findings were submitted to the UK statistics watchdog as part of its probe into the FDP data, which led to NHSE qualifying its claims and agreeing to involve the think-tank in the independent evaluation."}],[{"start":213.1,"text":"The health service first received a copy of the think-tank’s analysis in December 2025."}],[{"start":219.29999999999998,"text":"Last month MPs called on the government to trigger a 2027 break clause in Palantir’s contract and instead seek a UK-based provider. "}],[{"start":228.64999999999998,"text":"Palantir said in a statement that the Health Foundation report “appears to misunderstand what the tool does”, which is “supporting the more efficient discharge of long-stay patients with complex needs”."}],[{"start":240.09999999999997,"text":"“By lumping in the vast number of cases where patients are in hospital less than a week, they are comparing apples and oranges, and diluting the impact of the product,” it added."}],[{"start":249.39999999999998,"text":"NHS England said it had “engaged with the Health Foundation on its analysis of the OPTICA discharge tool, providing data and discussing the different approaches and methods used to assess impact. "}],[{"start":261.84999999999997,"text":"“We have commissioned a national independent evaluation of the Federated Data Platform for a more detailed assessment of its impact,” it added."}],[{"start":277.15,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1785136749_7286.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

AI股票泡沫终于要破裂了吗?

马丁:任何理性的人都能看出AI资产中不可持续的迹象。

埃森哲与“四大”瞄准中型企业市场谋增长

随着AI释放人力、降低服务成本,咨询巨头纷纷将目光投向规模较小的企业,希望以更低价格提供服务。

法拉奇:“我从未支持无休止的战争”

英国改革党领导人在美国共和党中期选举惨败后淡化了自己对伊朗战争的支持。

“蓝色浪潮”对美国经济变革的期待恐将落空

艾肯格林:美国国会的党派构成发生变化,对特朗普剩余任期内的政策制定影响不大。

民主党横扫中期选举,华尔街大金主押注失利

顶级对冲基金经理和私募股权投资公司高管为共和党竞选活动投入逾3亿美元,却几乎未见成效。
9小时前

美国的清晨,市场的黄昏

罗奇:美国中期选举结果再令人震惊,也阻止不了经济金融周期的转向。
设置字号×
最小
较小
默认
较大
最大
分享×